Shell Asset Management’s PTC Therapeutics PTCT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56K | Sell |
1,151
-120
| -9% | -$5.84K | ﹤0.01% | 1128 |
|
|
2025
Q1 | $65K | Sell |
1,271
-52
| -4% | -$2.66K | ﹤0.01% | 1099 |
|
|
2024
Q4 | $60K | Hold |
1,323
| – | – | ﹤0.01% | 1150 |
|
|
2024
Q3 | $49K | Buy |
+1,323
| New | +$49K | ﹤0.01% | 1184 |
|
|
2024
Q1 | $43K | Sell |
1,401
-81
| -5% | -$2.49K | ﹤0.01% | 1178 |
|
|
2023
Q4 | $41K | Sell |
1,482
-445
| -23% | -$12.3K | ﹤0.01% | 1198 |
|
|
2023
Q3 | $43K | Sell |
1,927
-29
| -1% | -$647 | ﹤0.01% | 1207 |
|
|
2023
Q2 | $80K | Sell |
1,956
-11
| -0.6% | -$450 | ﹤0.01% | 1158 |
|
|
2023
Q1 | $95K | Sell |
1,967
-7
| -0.4% | -$338 | ﹤0.01% | 1116 |
|
|
2022
Q4 | $75K | Sell |
1,974
-331
| -14% | -$12.6K | ﹤0.01% | 1222 |
|
|
2022
Q3 | $116K | Sell |
2,305
-620
| -21% | -$31.2K | ﹤0.01% | 1180 |
|
|
2022
Q2 | $117K | Buy |
2,925
+1,362
| +87% | +$54.5K | ﹤0.01% | 1249 |
|
|
2022
Q1 | $58K | Sell |
1,563
-236
| -13% | -$8.76K | ﹤0.01% | 1336 |
|
|
2021
Q4 | $72K | Sell |
1,799
-29
| -2% | -$1.16K | ﹤0.01% | 1349 |
|
|
2021
Q3 | $68K | Sell |
1,828
-70
| -4% | -$2.6K | ﹤0.01% | 1345 |
|
|
2021
Q2 | $80K | Hold |
1,898
| – | – | ﹤0.01% | 1397 |
|
|
2021
Q1 | $90K | Sell |
1,898
-3,304
| -64% | -$157K | ﹤0.01% | 1306 |
|
|
2020
Q4 | $317K | Hold |
5,202
| – | – | 0.01% | 980 |
|
|
2020
Q3 | $243K | Hold |
5,202
| – | – | 0.01% | 980 |
|
|
2020
Q2 | $264K | Sell |
5,202
-80
| -2% | -$4.06K | 0.01% | 946 |
|
|
2020
Q1 | $236K | Sell |
5,282
-80
| -1% | -$3.57K | 0.01% | 960 |
|
|
2019
Q4 | $258K | Sell |
5,362
-138
| -3% | -$6.64K | 0.01% | 1086 |
|
|
2019
Q3 | $186K | Sell |
5,500
-47
| -0.8% | -$1.59K | ﹤0.01% | 1141 |
|
|
2019
Q2 | $250K | Buy |
+5,547
| New | +$250K | 0.01% | 1080 |
|